Results 11 to 20 of about 50,432 (228)

HTLV-1 Disease

open access: yesPathogens, 2021
The years 2020 and 2021 will remain memorable years for many reasons [...]
Journo, Chloé, Martin, Fabiola
openaire   +6 more sources

Comparative virology of HTLV-1 and HTLV-2 [PDF]

open access: yesRetrovirology, 2019
Human T cell leukemia virus type 1 (HTLV-1) was the first discovered human retrovirus and the etiologic agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. Shortly after the discovery of HTLV-1, human T-cell leukemia virus type 2 (HTLV-2) was isolated from a patient with hairy cell leukemia.
Michael P. Martinez   +2 more
openaire   +3 more sources

Clinical characteristics and outcomes of infection with human T-lymphotropic virus in a non-endemic area: a single institution study

open access: yesFrontiers in Microbiology, 2023
IntroductionUnderstanding of human T-lymphotropic virus (HTLV) remains largely based on epidemiologic and clinical data from endemic areas. Globalization has resulted in migration of persons living with HTLV (PLHTLV) from endemic to non-endemic areas ...
Margery Gang   +4 more
doaj   +1 more source

HTLV-1/2 Infection in Blood Donors from a Non-Endemic Area (Catalonia, Spain) between 2008 and 2017: A 10-Year Experience

open access: yesViruses, 2022
Human T-cell lymphotropic virus type 1 and 2 (HTLV-1/2) screening is not mandatory in Spanish blood banks. In Catalonia, selective screening was introduced in 2008, followed by universal screening in 2011.
Maria Piron   +8 more
doaj   +1 more source

HTLV-1 Uveitis [PDF]

open access: yesFrontiers in Microbiology, 2012
Human T cell lymphotropic virus type 1 (HTLV-1) is the first retrovirus described as a causative agent of human disease. Following adult T cell leukemia/lymphoma and HLTV-1-associated myelopathy/tropical spastic paraparesis, HTLV-1 uveitis (HU) has been established as a distinct clinical entity caused by HTLV-1 based on seroepidemiological, clinical ...
Kamoi, Koju, Mochizuki, Manabu
openaire   +3 more sources

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis [PDF]

open access: yes, 2011
Background: Human T lymphotropic virus Type 1 (HTLV-1) causes a chronic inflammatory disease of the central nervous system known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM) which resembles chronic spinal forms of multiple ...
Stumpf, M. P. H. (Michael P. H.)   +43 more
core   +1 more source

Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections

open access: yesFrontiers in Public Health, 2022
A multi-epitope protein expressed in a prokaryotic system, including epitopes of Env, Gag, and Tax proteins of both HTLV-1 and HTLV-2 was characterized for HTLV-1/2 serological screening.
Gabriela de Melo Franco   +22 more
doaj   +1 more source

No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms [PDF]

open access: yes, 2007
Background The Deltaretrovirus genus comprises viruses that infect humans (HTLV), various simian species (STLV) and cattle (BLV). HTLV-I is the main causative agent in adult T-cell leukemia in endemic areas and some of the simian T-cell lymphotropic ...
Hummel, Michael   +9 more
core   +1 more source

HTLV-1 prevalence according to age for 386 female and 334 male community residents.

open access: yes, 2021
HTLV-1 infection was confirmed for 218 participants, using HTLV-1 western blots (WB) and/or HTLV-1 PCR (WB positive/PCR positive, 209; indeterminate WB/PCR positive, 8; tested by dried blood spot, PCR positive, 1).
Antoine Gessain (31917)   +7 more
core   +1 more source

Spread of Human T-Lymphotropic Virus 1 and 2 Among Relatives of People Who Use Illicit Drugs in Northern Brazil

open access: yesFrontiers in Microbiology, 2022
The human T-lymphotropic virus 1 (HTLV-1) and 2 (HTLV-2) can be transmitted between humans by mechanisms associated with horizontal and vertical routes.
Aldemir Branco Oliveira-Filho   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy